OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
September 02, 2014
A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.
With a quality-by-design approach, robust processes consistently can help deliver quality product.
September 01, 2014
Biopharma manufacturers must reduce risk in their complex supply chains and establish effective monitoring and control systems.
Changing regulations are impacting the identification and monitoring of variable materials in excipients.
New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.
Biopharma are looking to reduce risk, increase performance, and optimize productivity in raw material development.